🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the pharmacokinetics, safety, and ...
Status
Terminated
Location
CMAX
Start Date
2021-08-31
Trial ID
NCT05028114
AC-1202 (Ketasyn) is a nutritional beverage currently being studied in neur...
Status
Completed
Location
Meridien Research Center
Start Date
2008-04
Trial ID
NCT00660088
Treatments Being Tested
This is a Phase I, open label, randomized, 6-way crossover, pilot PK study...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-02-13
Trial ID
NCT03635879
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability and effec...
Status
Completed
Location
21st Century Neurology, a division of Xenoscience Inc.
Start Date
2004-11-04
Trial ID
NCT00142805
Treatments Being Tested
To compare serum ketone body (i.e., total ketones, β hydroxybutyrate, and e...
Status
Completed
Location
Celerion
Start Date
2016-11
Trial ID
NCT02959710
Treatments Being Tested
To compare serum ketone body (i.e., total ketones, β hydroxybutyrate, and e...
Status
Completed
Location
Celerion
Start Date
2017-03-11
Trial ID
NCT03063645
Treatments Being Tested
Phase 1, Single-center, Open-label Study, Healthy Adult Male Subjects. Par...
Status
Completed
Location
Nucleus Network
Start Date
2019-08-30
Trial ID
NCT03971123
Treatments Being Tested
To compare serum ketone body (i.e., total ketones, β hydroxybutyrate, and e...
Status
Completed
Location
Celerion, Inc
Start Date
2016-07
Trial ID
NCT02833012
Treatments Being Tested
The purpose of this study is to determine whether tricaprilin, a compound t...
Status
Completed
Location
Meridien Research
Start Date
2006-07
Trial ID
NCT00355550
Treatments Being Tested
This study will examine the brain metabolic effects of AC-1202 (Axona®), a ...
Status
Completed
Location
200 Medical Plaza, UCLA Medical Center
Start Date
2010-10
Trial ID
NCT01122329
Treatments Being Tested